The heterologous (non-specific) effects of vaccines: Implications for policy in high-mortality countries

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 109, Issue 1, 2014, Pages 5-8

  Shann, Frank ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Child; Developing countries; Heterologous immunity; Immunization; Non specific effects; Vaccines

Indexed keywords

BCG VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; MEASLES VACCINE; ORAL POLIOMYELITIS VACCINE; RETINOL; VACCINE; VITAMIN;

ARTICLE; DEVELOPING COUNTRY; DIPHTHERIA; HEALTH CARE POLICY; HETEROLOGOUS IMMUNITY; HUMAN; MORTALITY; PERTUSSIS; PNEUMONIA; SEPSIS; TETANUS; VACCINATION; CHILD; CHILDHOOD MORTALITY; COMMUNICABLE DISEASE; DIET SUPPLEMENTATION; DRUG EFFECTS; FEMALE; IMMUNIZATION; IMMUNOLOGY; INFANT; MALE; OBSERVATIONAL STUDY; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEX DIFFERENCE; TRENDS;

BCG VACCINE; CHILD; CHILD MORTALITY; CHILD, PRESCHOOL; COMMUNICABLE DISEASES; DEVELOPING COUNTRIES; DIETARY SUPPLEMENTS; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FEMALE; HEALTH POLICY; HUMANS; IMMUNITY, HETEROLOGOUS; IMMUNIZATION; INFANT; MALE; MEASLES VACCINE; OBSERVATIONAL STUDY AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEX FACTORS; VITAMIN A; VITAMINS;

EID: 84928881942     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1093/trstmh/tru161     Document Type: Article

References (23)

1. Shann F. The non-specific effects of vaccines. Arch Dis Child 2010;95:662-7.
2. Shann F. Nonspecific effects of vaccines and the reduction of mortality in children. Clin Ther 2013;35:109-14.
3. Aaby P, Whittle H, Benn CS. Vaccine programmes must consider their effect on general resistance. BMJ 2012;344:e3769.
4. Benn CS, Netea MG, Selin LK, Aaby P. A small jab - a big effect:nonspecific immunomodulation by vaccines. Trends Immunol 2013;34:431-9.
5. Aaby P, Roth A, Ravn H et al. Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period? J Infect Dis 2011;204:245-52.
6. Biering-Sorensen S, Aaby P, Napirna B et al. Small randomized trial among low-birth-weight children of Bacillus Calmette-Guerin vaccination at first health center contact. Pediatr Infect Dis J 2012;31:306-8.
7. Roth AE, Benn CS, Ravn H et al. Effect of revaccination with BCG in early childhood on mortality: randomised trial in Guinea-Bissau. BMJ 2010;340:c671.
8. Aaby P, Martins CL, Garly ML et al. Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality:randomised controlled trial. BMJ 2010;341:c6495.
9. Aaby P, Martins CL, Garly ML et al. Measles vaccination in the presence or absence of maternal measles antibody: impact on child survival. Clin Infect Dis 2014;59:484-92.
10. Aaby P, Samb B, Simondon F et al. Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries. BMJ 1995;311:481-5.
11. Aaby P, Benn C, Nielsen J et al. Testing the hypothesis that diphtheria-tetanus-pertussis vaccine has negative non-specific and sex-differential effects on child survival in high-mortality countries. BMJ Open 2012;2:pii:e000707.
12. WHO. Nonspecific effects of vaccines on childhood mortality. Wkly Epidemiol Rec 2014;89:233-5.
13. Comstock GW. Simple, practical ways to assess the protective efficacy of a new tuberculosis vaccine. Clin Infect Dis 2000;30(Suppl 3):S250-3.
14. Favorov M, Ali M, Tursunbayeva A et al. Comparative tuberculosis (TB) prevention effectiveness in children of Bacillus Calmette-Gué rin (BCG) Vaccines from different sources, Kazakhstan. PLoS One 2012;7:e32567.
15. Shirey M, Noertoft D, Sullivan A. Bacillus Calmette-Guerin (BCG) vaccine: supply and demand update - September 2013. www.unicef. org/supply/files/BCG_Supply_Status.pdf [accessed 5 July 5 2014].
16. Garly ML, Balé C, Martins CL et al. Measles antibody responses after early two dose trials in Guinea-Bissau with Edmonston-Zagreb and Schwarz standard-titre measles vaccine: better antibody increase from booster dose of the Edmonston-Zagreb vaccine. Vaccine 2001;19:1951-9.
17. Svensson S, Menkes DB, Lexchin J. Surrogate outcomes in clinical trials:a cautionary tale. JAMA Intern Med 2013;173:611-2.
18. Ramachandrappa A, Jain L. Iatrogenic disorders in modern neonatology: a focus on safety and quality of care. Clin Perinatol 2008;35:1-34.
19. WHO. Reported immunization schedules by vaccine in excel. Geneva:World Health Organization; 2014. www.who.int/entity/immunization/monitoring_surveillance/data/schedule_data.xls?ua=1 [accessed 17 July 2014].
20. Edwards K, Decker M. Pertussis vaccines. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines 6th ed. Philadelphia: Saunders; 2013. p 447-92.
21. Benn CS. Combining vitamin A and vaccines: convenience or conflict? Dan Med J 2012;59:B4378.
22. Fisker A, Bale C, Rodrigues A et al. High-dose vitamin A at vaccination contacts after 6 months of age: a randomized trial. Pediatrics 2014;134:e739-48.
23. Awasthi S, Peto R, Read S et al. Vitamin A supplementation every 6 months with retinol in 1 million pre-school children in north India:DEVTA, a cluster-randomised trial. Lancet 2013;381:1469-77.